Evaluating coronary stenosis prognosis using intracoronary imaging
Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study
This study is testing how advanced imaging techniques can help doctors understand the long-term health of patients with narrowed heart arteries.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 4000 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Asan Medical Center Academic / other |
| Locations | 15 sites (Seoul, Songpa-gu and 14 other locations) |
| Trial ID | NCT02792075 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the prognosis of coronary stenosis by utilizing advanced intracoronary imaging techniques such as VH-IVUS, OCT, and NIRS. It involves a multicenter approach with a 5-year follow-up period to gather comprehensive data on patients with coronary artery disease. Participants will undergo intracoronary imaging and will be monitored over time to evaluate outcomes related to their coronary health.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with coronary artery disease who can undergo intracoronary imaging and provide written consent.
Not a fit: Patients with severe calcification, previous bypass surgery, or significant comorbidities may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the prognosis of coronary artery disease, potentially leading to improved patient management and treatment strategies.
How similar studies have performed: Other studies utilizing intracoronary imaging techniques have shown promise in improving the understanding of coronary artery disease, suggesting that this approach may yield beneficial results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with intracoronary imaging * Written consent Exclusion Criteria: * Severe calcification and/or severe tortuosity * Lesion with previous bypass graft surgery (CABG) * Left ventricular ejection fraction less than 30 % * Coronary spasm * Life expectancy less than 2 years * Pregnancy or breast-feeding
Where this trial is running
Seoul, Songpa-gu and 14 other locations
- Asan Medical Center — Seoul, Songpa-gu, South Korea (Recruiting)
- Inje University Busan Paik Hospital — Busan, South Korea (Recruiting)
- Soon Chun Hyang University Hospital Cheonan — Cheonan, South Korea (Recruiting)
- Keimyung University Dongsan Medical Center — Daegu, South Korea (Recruiting)
- Chungnam National University Hospital — Daejeon, South Korea (Recruiting)
- Inje University Ilsan Paik Hospital — Ilsan, South Korea (Recruiting)
- Gachon University Gil Hospital — Incheon, South Korea (Terminated)
- Jeju national university hospital — Jeju City, South Korea (Recruiting)
- Pusan National University Hospital — Pusan, South Korea (Recruiting)
- Chung-Ang university hospital — Seoul, South Korea (Recruiting)
- Kangbuk Samsung Hospital — Seoul, South Korea (Withdrawn)
- Korea University Guro Hospital — Seoul, South Korea (Recruiting)
- Ajou University Hospital — Suwon, South Korea (Active_not_recruiting)
- Ulsan University Hospital — Ulsan, South Korea (Withdrawn)
- Wonju Severance Christian Hospital — Wŏnju, South Korea (Recruiting)
Study contacts
- Study coordinator: Seung-jung Park, MD
- Email: sjpark@amc.seoul.kr
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.